PMC:4134656 / 27336-27531 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4134656","sourcedb":"PMC","sourceid":"4134656","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4134656","text":"Other systemic drugs\nOther treatment options like interferon α, vincristine and cyclophosphamide are reserved for life-threatening haemangiomas which are unresponsive to conventional therapy.[47]","divisions":[{"label":"title","span":{"begin":0,"end":20}}],"tracks":[{"project":"2_test","denotations":[{"id":"25136206-15792110-58659607","span":{"begin":192,"end":194},"obj":"15792110"}],"attributes":[{"subj":"25136206-15792110-58659607","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#ecc193","default":true}]}]}}